Deltex Medical Group plc
("Deltex Medical" or "the Company")
Director/PDMR Shareholding
17 May 2013 - Deltex Medical Group (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has received notification that its Finance Director, Paul Mitchell, on 13 May 2013 and 16 May 2013 transferred a total of 93,478 Ordinary Shares into his Self Invested Personal Pension. This was achieved by his broker selling 93,478 shares to the pension fund at 13.81 pence per share and using the proceeds to repurchase 91,979 shares from Paul Mitchell at a price of 13.95 pence per share. As a result of the different prices at which the two transactions occurred, Paul Mitchell purchased a further 1,499 ordinary shares at a price of 14.20 pence per share in order to ensure his beneficial holding remained unchanged.
As a result of this transaction Paul Mitchell's total beneficial holding remains unchanged at 269,974 Ordinary Shares in the Company representing 0.16% of the total issued ordinary share capital of the Company.
For further information, please contact:
Deltex Medical Group plc |
01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman |
|
Ewan Phillips, Chief Executive |
|
Paul Mitchell, Finance Director |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
Chris Hardie |
|
|
|
Financial Public Relations |
|
Newgate Threadneedle |
020 7653 9850 |
Graham Herring |
|
Caroline Evans-Jones |
|
Heather Armstrong |
|